Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
Andreas Zimprich Foundation

Andreas Zimprich-Foundation

Promotion of research on brain tumors

Andreas Zimprich Foundation

Andreas Zimprich
© private

Andreas Zimprich died of a brain tumor at the age of 48. His parents Marianne and Egon Zimprich established the Andreas Zimprich-Foundation in his memory together with the German Cancer Research Center. The benefactors from Heilbronn would like to advance research in the field of neuro-oncology. Patients with glioma should have better chances in the future for a successful treatment than their son. Since 2010 the foundation has been committed to promoting the development of innovative methods of treatment for brain tumors.

Your contact person

Elisabeth Hohensee

Office of Development
German Cancer Research Center
Phone: +49 6221 42-2848

Help support brain tumor research: By donating to the Andreas Zimprich-Foundation you can support the development of new methods of treatment.

Donation account Andreas Zimprich-Foundation:
IBAN: DE74 6205 0000 0000 2286 86

All donations are tax deductable. Shortly after receipt of payment you will receive the donation receipt. Please provide your address on your money order. You can also support the Andreas Zimprich-Foundation through an endowment contribution. Should you choose to do so, please feel free to contact us.

The trust foundation awards young researchers

Since 2015 the foundation has presented the Andreas Zimprich-Prize for an outstanding medical dissertation in the field of neuro-oncology. The prize money is financed through donations to the foundation and revenues from the endowment capital. This prize is awarded every two years and is endowed with 2,500 EUR.

Here you can find the current calls.

Christoph Geisenberger (left) during the presentation of the Andreas Zimprich-Prize at DKFZ
© DKFZ/Uwe Anspach

The 2019 Andreas Zimprich-Prize was awarded to Erik Jung. The award winner works as a physician at the Neurological Department at the Heidelberg University Hospital and as a scientist at the German Cancer Research Center. In his dissertation, he investigated novel therapeutic approaches for malignant gliomas.

In 2017 the Andreas Zimprich-Prize was awarded to Christoph Geisenberger. He received the award for his research on the biological properties of glioblastomas, associated with long-term survival. His research was carried out in the Neurosurgical Clinic at the University Hospital in Heidelberg.

The photo shows the prizewinner for 2017 (left) together with other prize-winning scientists, at the award ceremony held at the German Cancer Research Center.

Lukas Bunse Zimprich-Award 2015

Lukas Bunse received an award for the development of a vaccine to treat brain tumors.
© DKFZ/Yan de Andres

The first prizewinner in 2015 was Lukas Bunse, physician and scientist at the Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology at DKFZ and the University Hospital Heidelberg. In his doctoral thesis, Lukas Bunse focused on the development of a vaccine against brain tumors.

The photo shows the prizewinner 2015 (middle) together with the Scientific Director of DKFZ, Prof. Michael Boutros (far left), the Laudatory Speaker Prof. Wolfgang Wick (second from the right) as well as Andreas Zimprich’s brother and father (far right).

Trustee: German Cancer Research Center Heidelberg
Prof. Dr. Michael Baumann, Chairman of the Management Board and Scientific Director, Ursula Weyrich, Administrative Director
Address: Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Phone: +49 6221 42-2860 Fax: +49 6221 42-2840
Tax Nr. 32489/31552, Tax Office Heidelberg
Board of Trustees of the Andreas Zimprich-Foundation: Prof. Dr. Wolfgang Wick, Dr. Rolf Zimmermann, Heidelberg; Prof. Dr. Daniel Zimprich, Ulm

to top
powered by webEdition CMS